Last reviewed · How we verify
NCT03105739
Timing of Withdrawal of the Laryngeal Mask Airway (LMA) in Children
NA trial testing LMA removal in Laryngeal Mask Airway Removal in 148 participants. Completed in 30 March 2017.
29 March 2017
Quick facts
| Lead sponsor | Hôpital d'enfants Béchir-Hamza |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 148 |
| Start date | 5 October 2016 |
| Primary completion | 29 March 2017 |
| Estimated completion | 30 March 2017 |
| Sites | 1 location across Tunisia |
Drugs / interventions tested
- LMA removal
Conditions studied
- Laryngeal Mask Airway Removal — all drugs for Laryngeal Mask Airway Removal →
- Respiratory Complication — all drugs for Respiratory Complication →
Sponsor
Hôpital d'enfants Béchir-Hamza
Who can join
Adults 1 to 15, any sex, with Laryngeal Mask Airway Removal or Respiratory Complication. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this prospective, randomized study was to compare the incidence of adverse events associated with removal of the LMA either in deeply anesthetised or awake patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03105739
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of LMA removal
Trials testing the same drug.
- NCT04711174 — Optimization for Laryngeal Mask Removal Strategy and Evaluation of Transitional Criteria From PACU in Children · completed
Other Hôpital d'enfants Béchir-Hamza trials
Trials by the same sponsor.
- NCT04049201 — Interactive Tablet Compared to Oral Midazolam as Premedication in Preoperative Anxiety in Children · NA · completed
- NCT03505814 — Interest of High Flow Nasal Cannula Oxygen Therapy in Pediatric Intensive Care Unit · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03105739 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hôpital d'enfants Béchir-Hamza
- Last refreshed: 10 April 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03105739.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing